In this episode of "The Top Line," our Fierce reporters tackle topics like the trends we saw at Cannes Lions, the cancer drug shortage, and the top compensated CEOs in the industry. 
To learn more about the topics in this episode:

National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them
FDA to allow temporary overseas production to shore up supplies of chemo drug
FDA can't solve drug shortages on its own, agency's oncology chief says
Play it loud: Cannes winner pitches sound therapy as extra tool in arsenal against cancer
How Eversana roared back from rejection to craft Cannes-winning campaign hospitals couldn't ignore
In a year of turnover, Seagen doled out $126M to a trio of CEOs
The 15 highest paid pharma CEOs of 2021
UPDATED: Moderna CEO Stéphane Bancel earned $19.4M in 2022 but made much more in stock sales

"The Top Line" and "Podnosis" are produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.